Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 178


Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis.

Kaijser J, Sayasneh A, Van Hoorde K, Ghaem-Maghami S, Bourne T, Timmerman D, Van Calster B.

Hum Reprod Update. 2014 May-Jun;20(3):449-62. doi: 10.1093/humupd/dmt059. Epub 2013 Dec 9. Review.


Multicentre external validation of IOTA prediction models and RMI by operators with varied training.

Sayasneh A, Wynants L, Preisler J, Kaijser J, Johnson S, Stalder C, Husicka R, Abdallah Y, Raslan F, Drought A, Smith AA, Ghaem-Maghami S, Epstein E, Van Calster B, Timmerman D, Bourne T.

Br J Cancer. 2013 Jun 25;108(12):2448-54. doi: 10.1038/bjc.2013.224. Epub 2013 May 14.


Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.

Di Legge A, Testa AC, Ameye L, Van Calster B, Lissoni AA, Leone FP, Savelli L, Franchi D, Czekierdowski A, Trio D, Van Holsbeke C, Ferrazzi E, Scambia G, Timmerman D, Valentin L.

Ultrasound Obstet Gynecol. 2012 Sep;40(3):345-54. doi: 10.1002/uog.11167. Epub 2012 Aug 7.


Should cut-off values of the risk of malignancy index be changed for evaluation of adnexal masses in Asian and Pacific populations?

Yavuzcan A, Caglar M, Ozgu E, Ustun Y, Dilbaz S, Ozdemir I, Yildiz E, Gungor T, Kumru S.

Asian Pac J Cancer Prev. 2013;14(9):5455-9.


Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies.

Kaijser J, Bourne T, Valentin L, Sayasneh A, Van Holsbeke C, Vergote I, Testa AC, Franchi D, Van Calster B, Timmerman D.

Ultrasound Obstet Gynecol. 2013 Jan;41(1):9-20. doi: 10.1002/uog.12323. Review.


External validation of diagnostic models to estimate the risk of malignancy in adnexal masses.

Van Holsbeke C, Van Calster B, Bourne T, Ajossa S, Testa AC, Guerriero S, Fruscio R, Lissoni AA, Czekierdowski A, Savelli L, Van Huffel S, Valentin L, Timmerman D.

Clin Cancer Res. 2012 Feb 1;18(3):815-25. doi: 10.1158/1078-0432.CCR-11-0879. Epub 2011 Nov 23.


A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass.

Kaijser J, Van Gorp T, Van Hoorde K, Van Holsbeke C, Sayasneh A, Vergote I, Bourne T, Timmerman D, Van Calster B.

Gynecol Oncol. 2013 May;129(2):377-83. doi: 10.1016/j.ygyno.2013.01.018. Epub 2013 Jan 27.


Clinically oriented three-step strategy for assessment of adnexal pathology.

Ameye L, Timmerman D, Valentin L, Paladini D, Zhang J, Van Holsbeke C, Lissoni AA, Savelli L, Veldman J, Testa AC, Amant F, Van Huffel S, Bourne T.

Ultrasound Obstet Gynecol. 2012 Nov;40(5):582-91. doi: 10.1002/uog.11177.


Menopausal status strongly influences the utility of predictive models in differential diagnosis of ovarian tumors: an external validation of selected diagnostic tools.

Moszynski R, Zywica P, Wojtowicz A, Szubert S, Sajdak S, Stachowiak A, Dyczkowski K, Wygralak M, Szpurek D.

Ginekol Pol. 2014 Dec;85(12):892-9.


Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.

Valentin L, Ameye L, Savelli L, Fruscio R, Leone FP, Czekierdowski A, Lissoni AA, Fischerova D, Guerriero S, Van Holsbeke C, Van Huffel S, Timmerman D.

Ultrasound Obstet Gynecol. 2011 Oct;38(4):456-65. doi: 10.1002/uog.9030. Epub 2011 Sep 13.


Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group.

Timmerman D, Ameye L, Fischerova D, Epstein E, Melis GB, Guerriero S, Van Holsbeke C, Savelli L, Fruscio R, Lissoni AA, Testa AC, Veldman J, Vergote I, Van Huffel S, Bourne T, Valentin L.

BMJ. 2010 Dec 14;341:c6839. doi: 10.1136/bmj.c6839.


The risk of malignancy index in discrimination of adnexal masses.

Ulusoy S, Akbayir O, Numanoglu C, Ulusoy N, Odabas E, Gulkilik A.

Int J Gynaecol Obstet. 2007 Mar;96(3):186-91. Epub 2007 Feb 5.


Evaluation of the risk malignancy index diagnostic value in patients with adnexal masses.

Terzić M, Dotlić J, Ladjević IL, Atanacković J, Ladjević N.

Vojnosanit Pregl. 2011 Jul;68(7):589-93.


Prospective evaluation of the IOTA logistic regression model LR2 for the diagnosis of ovarian cancer.

Nunes N, Yazbek J, Ambler G, Hoo W, Naftalin J, Jurkovic D.

Ultrasound Obstet Gynecol. 2012 Sep;40(3):355-9. doi: 10.1002/uog.11088.


Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study.

Testa A, Kaijser J, Wynants L, Fischerova D, Van Holsbeke C, Franchi D, Savelli L, Epstein E, Czekierdowski A, Guerriero S, Fruscio R, Leone FP, Vergote I, Bourne T, Valentin L, Van Calster B, Timmerman D.

Br J Cancer. 2014 Aug 12;111(4):680-8. doi: 10.1038/bjc.2014.333. Epub 2014 Jun 17.


Use of IOTA simple rules for diagnosis of ovarian cancer: meta-analysis.

Nunes N, Ambler G, Foo X, Naftalin J, Widschwendter M, Jurkovic D.

Ultrasound Obstet Gynecol. 2014 Nov;44(5):503-14. doi: 10.1002/uog.13437. Epub 2014 Oct 13. Review.


Preoperative identification of a suspicious adnexal mass: a systematic review and meta-analysis.

Dodge JE, Covens AL, Lacchetti C, Elit LM, Le T, Devries-Aboud M, Fung-Kee-Fung M; Gynecology Cancer Disease Site Group.

Gynecol Oncol. 2012 Jul;126(1):157-66. doi: 10.1016/j.ygyno.2012.03.048. Epub 2012 Apr 6. Review.


Risk of malignancy index for adnexal masses.

Akdeniz N, Kuyumcuoğlu U, Kale A, Erdemoğlu M, Caca F.

Eur J Gynaecol Oncol. 2009;30(2):178-80.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk